AKT1 and pulmonary fibrosis: Several pro-fibrotic pathways, including Akt and ERK, are inhibited by GHRH-R antagonists including MIA-602, demonstrating that GHRH plays a key role in modulating lung fibrosis following inflammation by blocking these pathways [1,34].